Continuing Medical Education
Accreditation Statement
The American Association for Cancer Research (AACR) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education activities for physicians.
Credit Designation Statement
AACR has designated this live activity for a maximum of 30.50 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Credit certification for individual sessions may vary, dependent upon compliance with the ACCME Accreditation Criteria. The final number of credits may vary from the maximum number indicated above.
CLAIMING (CME) CREDIT
Physicians and other health care professionals seeking AMA PRA Category 1 Credit(s)TM for this live continuing medical education activity must complete the online CME Request for Credit Survey by September 8, 2024. Certificates will only be issued to those who complete the survey. Your CME certificate will be sent to you via email after the completion of the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 30.50 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
To receive ABIM MOC, participants must request MOC in the CME Request for Credit Survey and complete all questions. Once these steps are completed, AACR will submit your completion information via the ACCME’s Program and Activity Reporting System for the purpose of granting MOC points.
Statement of Educational Need, Target Audience, and Learning Objectives
Our basic understanding of cancer has grown exponentially over the past decade. This expansion has been driven in large part by comprehensive cancer genome characterization, new knowledge of epigenetics and chromatin biology across tumor cell states, enhanced imaging capabilities in both clinical and preclinical contexts, new technologies for high-throughput functional studies, and the emergence of the immune system as a crucial—and therapeutically tractable—modulator of tumor progression.
Despite these impressive advances, their successful translation to the diagnosis, treatment, and prevention of cancer remains challenging. Paradoxically, the same frenzied pace of advances in cancer research today may worsen several obstacles to its successful clinical application. This is because many oncologists have difficulty keeping up with the latest research developments and their potential clinical impact—even in academic settings. The language, methodologies, and new technologies used in patient-oriented research may seem increasingly rarefied to the clinician. Conversely, basic scientists frequently lack knowledge of the salient unanswered medical questions that clinical oncologists face; thus, they may be hampered in their ability to configure fundamental discoveries into clinically meaningful frameworks. As a result, a translational gap exists between basic scientists and clinicians, which is manifested at the conceptual, methodological, and educational levels.
In principle, physician-scientists trained in oncology should represent a natural cohort of investigators to bridge this gap. Toward this end, several lines of evidence indicate that physician-scientists remain an integral component of biomedical research in general and clinical translation in particular. Once properly trained, they are particularly well-suited to conduct the “bench to bedside” and “bedside to bench” translational cancer research essential for improving patient care.
After participating in this CME activity, physicians should be able to:
- Comprehend the principles of molecular biology and scientific experimental design in translational cancer research as applicable to physician-scientists.
- Understand and practice experimental methods used in molecular oncology and translational cancer research.
- Design hypothesis-driven aims and robust experiments through grant writing exercises.
DISCLOSURE STATEMENT
It is the policy of the AACR that the information presented at AACR CME activities will be unbiased and based on scientific evidence. To help participants make judgments about the presence of bias, AACR will provide information that Scientific Program Committee members and speakers have disclosed all financial relationships they have with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products or services used by or on patients. All of the relevant financial relationships for these individuals have been mitigated.
ACKNOWLEDGMENT OF FINANCIAL OR OTHER SUPPORT
The AACR gratefully acknowledges the following commercial supporters for their Professional Educational Grants:
- Pfizer
QUESTIONS ABOUT CME?
Please read our frequently asked questions. If you still have questions, contact the Office of CME at (215) 440-9300 or [email protected].